Pathway Health (TSX-V:PHC) President Wayne Cockburn joined Steve Darling from Proactive to share news the company has entered into a Service Agreement with Canntab Therapeutics which has a focus on the manufacturing and distribution of oral tablet cannabinoid products.
Cockburn telling Proactive the deal gives the company a chance to provide Canntab’s oral tablet cannabinoid products their patients and partners. The products are expected to have a range of dosages of both THC and CBD medications.